MicroPort Scientific : Dongguan Kewei Disposable Arterial Micro Plug Filter Obtained EU...

Shanghai, China-Recently, independently researched and the Disposable Arterial Micro Plug Filter which developed by Dongguan Kewei Medical Instrument Co., Ltd. ('Dongguan Kewei'), obtained the official CE Certification of EU. This is Dongguan Kewei's first CE certified product, marking that Dongguan Kewei has taken the significant milestone in the road of globalization.

The Disposable Arterial Micro Plug Filter is a filtering device used to clean the small emboli of blood after oxygenation. It is the last safety barrier in cardiopulmonary bypass surgeries. Using arterial micro plug filter can greatly reduce post-operative complications. Dongguan Kewei Disposable Arterial Micro Plug Filter has the features of small pressure drop, excellent performance of filtering, clear flow route and easy to observe. The product adopts a folding structure design, with a large filtration area. During surgery, blood can have tangential entry, thus reduced the damage of blood cell. In addition, the product is provided with an exhaust hole, exhaust and piezo metric tube can have a free connection, which made exhaust more convenient.

Before this, Dongguan Kewei Disposable Arterial Micro Plug Filter has been obtained CFDA registration certificate. It has been widely used in cardiopulmonary bypass surgery, has a relatively high market share. Its safety and effectiveness has won the recognition of the patients and the doctors. The obtaining of EU CE certification means that the product will officially enter the EU market, and so will bring more benefits to overseas patients.

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 18 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2016 MicroPort Scientific Corporation

CONTACT:

Jonathan Chen Senior Vice President, International Operations and Investor Relations MicroPort Scientific Corporation Tel: [phone] Email: [e-mail]

Priscilla Li Manager of Shareholders and Security Affairs Shanghai MicroPort Medical (Group) Co., Ltd. (HQ) Tel: [phone]-6958 Email: [e-mail]